Sanjana Rane

Sanjana Rane, MD, MBA is an Internal Medicine resident (PGY-2) at Massachusetts General Hospital. She received her MD from Harvard Medical School and MBA from Harvard Business School. Her clinical interests center on hepatology, particularly metabolic dysfunction-associated steatotic liver disease (MASLD), cirrhosis, and alcohol-associated liver disease. Her broader academic interests lie at the intersection of clinical outcomes, healthcare operations, and innovation, including the use of real-world data and novel study designs such as target trial emulation to inform clinical care.

Brandon J Peiffer

I Graduated from Millersville University (PA) with B.S. in Biochemistry in 2014, then completed my Ph.D. in Chemical Biology at Johns Hopkins University (MD) in 2019. I am currently an instructor in the department of surgery at the Johns Hopkins School of Medicine performing research on alcohol-associated liver diseases.

Mario Romeo

Mario Romeo, MD, PhD, is a gastroenterologist and hepatologist at the University Hospital of Campania "Luigi Vanvitelli," Naples, Italy. His research program focuses on precision hepatology and biology-driven phenotyping of chronic liver diseases, integrating genetic, metabolic, environmental and pathophysiological determinants with non-invasive biomarkers to improve individualized risk stratification and therapeutic decision-making. His main areas of interest include metabolic liver disease, cholangiopathies, cirrhosis and portal hypertension.

Thi Hao Vu

Vu Thi Hao, PhD, is a postdoctoral researcher at the Tokai University School of Medicine in Japan. My research focuses on cholestatic liver diseases and fibrosis, using CRISPR/Cas9-mediated genome editing, genetically modified mouse models, molecular biology, and transcriptomic analyses. I obtained my PhD in Animal Biotechnology from Chung-Ang University in South Korea and have research experience in Vietnam, South Korea, and Japan.

Subscribe to